Media
Talk to Our Care TeamImmunoACT’s advancements in CAR-T cell therapy in India have been featured across leading national and international media platforms. This section brings together independent coverage of our clinical progress, partnerships, and efforts to improve access to cell and gene therapy for cancer treatment. Explore how our work in indigenous CAR-T development and biotechnology innovation is being recognized by trusted news sources and industry voices.
Indigenous CAR-T therapy signals new phase for India's cancer care and biotech manufacturing
The Economic Times
20 Feb 2026Cipla to take indigenously made CAR-T cell therapy from ImmunoAct to Africa
Business Line
20 Jan 2026Indigenous CAR-T Therapy to Make Cancer Treatment More Affordable: Technology Developed by Dr. Rahul Purwar Successfully Completes Clinical Trials
Dainik Bhaskar
19 Jan 2026Mango Sciences Announces Partnership With ImmunoACT to Bring the World’s First Bridge Financing Plan and Value-Based Offering for CAR-T Therapy for Cancer Patients in India
Business Wire
05 Dec 2025PM Modi Unveils India’s First Indigenous CAR-T Cancer Therapy ‘NexCAR19’
Voice of Healthcare
06 Nov 2025PM Modi Unveils India’s First Quantum Chips and Indigenous CAR-T Cancer Therapy at ESTIC 2025
The Impressive Times
05 Nov 2025India Unveils Its First Indigenous CAR-T Cell Therapy, Paving the Way for Affordable Cancer Immunotherapy
Economic Times
05 Nov 2025Last shot at life: New Zealander picks Bangaluru for cancer treatment post media reports; Hails CAR-T cell Therapy
Times of India
21 Aug 2025First successful CAR-T Cell therapy for cancer patients in Oman
Times of Oman
18 Aug 2025